Skip to main content
. 2019 Feb 19;13:667–680. doi: 10.2147/DDDT.S166092

Figure 3.

Figure 3

Thirty-year-old female with Behçet’s disease showing development of macular edema on optical coherence tomography (A) and regression of intraretinal fluid 3 weeks following intravitreal injection of Ozurdex® (B).

Note: The patient was already on systemic treatment with infliximab.